The future of the BPCA looks promising, with continued efforts to refine and expand the act. There is ongoing discussion about enhancing incentives and streamlining the process to encourage more robust and comprehensive pediatric research. Future amendments may address existing challenges and further improve the quality and quantity of pediatric drug studies.
